Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic Leukemia in the United States: A large population-based study

Lignende værker

• Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): A large propensity score-matched population-based study
  af: Davidoff, Amy J., et al.
  Udgivet: (2019)
• Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States
  af: Zeidan, Amer M., et al.
  Udgivet: (2020)
• Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents
  af: Zeidan, Amer M., et al.
  Udgivet: (2019)
• Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents
  af: Giri, Smith, et al.
  Udgivet: (2020)
• Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation
  af: Zeidan, Amer M., et al.
  Udgivet: (2018)